ADAR1 Capital Management’s Verve Therapeutics VERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.27M Buy
+469,018
New +$5.27M 0.81% 31
2024
Q3
Sell
-44,000
Closed -$215K 313
2024
Q2
$215K Buy
+44,000
New +$215K 0.04% 132